Puritan's Pride

Triple Strength Joint Soother Glucosamine Boswellia + Magnesium

Serving
2 Tablet(s)
Per container
30
Form
tablet
UPC
025077000807
DSLD
Formula hash
c318231fc860
Brand context
Catalog
1,262
products
With avoid flag
100
products
FDA recalls
0
history
CAERS
453
reports
Avoid-flaggedObjective label signals
Flagged excipients
4
1 avoid · 3 caution
FDA recalls
0
no recall history
CAERS reports
373
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

3 active ingredients
IngredientAmount% DV
Magnesium
mineralUNII · I38ZP9992A
6 effects
1.2× ULexceeds NIH ODS adult upper limitsource →
420 mg100%
Glucosamine Hydrochloride
herbUNII · 750W5330FY
1500 mg
5-Loxin Advanced
Boswelliaherb
100 mg
What this product supports · authorized claims

6 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

4 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

  • ◐ CAUTIONFD&C Blue #2 Lake
    color

    Banned from direct food use in Norway; restricted in EU under Commission Regulation 1333/2008. FDA permits under 21 CFR 74.102 with labeling requirement.

  • ◐ CAUTIONFD&C Red #40 Lake
    color

    EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).

  • ◐ CAUTIONFD&C Yellow #5 Lake
    color

    EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).

FDA CAERS · adverse event context
373
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Cellulose · Crospovidone · Guar Gum · Magnesium Silicate · Maltodextrin · Medium Chain Triglyceride · Polydextrose · Silica · Magnesium Stearate · Stearic Acid